AVIR - Atea Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$10.00
DETAILS
HIGH:
$10.00
LOW:
$10.00
MEDIAN:
$10.00
CONSENSUS:
$10.00
UPSIDE:
126.24%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 351.4 | 48.6 | 0 | 0 |
| Cost of Revenue | 0 | 83.4 | 70.1 | 62.4 | 167.2 | 38.0 | 0.0 | 0.0 |
| Gross Profit | 0 | (83.4) | (70.1) | (62.4) | 184.2 | 10.6 | (0.0) | (0.0) |
| Operating Expenses | ||||||||
| R&D Expenses | 148.0 | 145.4 | 132.8 | 88.8 | 167.2 | 38.0 | 10.2 | 6.7 |
| SG&A Expenses | 32.9 | 48.8 | 49.9 | 48.7 | 45.8 | 21.6 | 4.4 | 2.8 |
| Other Expenses | 0 | (84.7) | (88.7) | (69.3) | (167.2) | (38.0) | 0 | 0 |
| Operating Expenses | 180.9 | 109.6 | 94.1 | 68.3 | 45.8 | 21.6 | 14.6 | 9.5 |
| Operating Income | ||||||||
| Operating Income | (180.9) | (192.9) | (164.2) | (130.7) | 138.4 | (11.0) | (14.6) | (9.5) |
| Interest Expense | 0 | 0 | 0 | 11.2 | 0 | 0 | 0 | 0 |
| Interest Income | 16.4 | 25.5 | 29.2 | 11.2 | 0.2 | 0.1 | 0.6 | 0.4 |
| Profitability | ||||||||
| EBITDA | (180.5) | (131.8) | (119.6) | (110.8) | 138.4 | (11.0) | (14.6) | (9.5) |
| EBIT | (180.9) | (132.2) | (120.0) | (111.1) | 138.4 | (11.0) | (14.6) | (9.5) |
| Income Before Tax | (164.5) | (167.5) | (134.9) | (119.5) | 138.6 | (10.9) | (14.0) | (9.1) |
| Income Tax Expense | (6.2) | 0.9 | 1.0 | (3.6) | 17.4 | 0 | 0 | 0 |
| Net Income | (158.3) | (168.4) | (136.0) | (115.9) | 121.2 | (10.9) | (13.5) | (9.1) |
| Per Share Data | ||||||||
| EPS (Basic) | -1.94 | -2.00 | -1.63 | -1.39 | 1.46 | -0.13 | -0.16 | -0.90 |
| EPS (Diluted) | -1.94 | -2.00 | -1.63 | -1.39 | 1.37 | -0.13 | -0.16 | -0.90 |
| Shares Outstanding | 81.5 | 84.3 | 83.4 | 83.2 | 82.8 | 82.4 | 82.6 | 10.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 95.7 | 64.7 | 143.8 | 646.7 | 764.4 | 850.1 | 21.7 | 34.5 |
| Short-Term Investments | 206.1 | 390.0 | 434.3 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 5.8 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 9.2 | 7.6 | 12.3 | 14.2 | 0 | 0 | 0.2 | 0 |
| Total Current Assets | 311.0 | 462.4 | 590.5 | 660.9 | 772.4 | 863.5 | 21.9 | 34.7 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 1.1 | 2.1 | 3.1 | 4.1 | 0.2 | 0.0 | 0.0 | 0.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0.2 | 0 | 0.1 | 0.1 | 0.1 |
| Other Non-Current Assets | 3.1 | 0.2 | 1.4 | 1.5 | 0.3 | 0 | 0.0 | 0 |
| Total Non-Current Assets | 4.2 | 2.3 | 4.5 | 5.8 | 0.5 | 0.2 | 0.2 | 0.2 |
| Total Assets | 315.2 | 464.7 | 595.0 | 666.7 | 772.9 | 863.6 | 22.1 | 34.9 |
| Current Liabilities | ||||||||
| Account Payables | 12.9 | 4.5 | 4.3 | 2.6 | 4.5 | 0.1 | 0.5 | 0.4 |
| Short-Term Debt | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 301.4 | 0.2 | 0.2 |
| Other Current Liabilities | 26.0 | 7.4 | 0 | 8.6 | 27.6 | 11.6 | 1.7 | 0.2 |
| Total Current Liabilities | 39.8 | 18.6 | 32.4 | 18.5 | 56.9 | 315.8 | 2.4 | 1.8 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 6.4 | 5.8 | 5.3 | 5.9 | 0.0 | 0.1 | 69.3 |
| Total Non-Current Liabilities | 0 | 7.2 | 7.4 | 7.7 | 5.9 | 0.0 | 0.1 | 69.3 |
| Total Liabilities | 39.8 | 25.8 | 39.8 | 26.1 | 62.8 | 315.8 | 2.5 | 71.0 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Retained Earnings | (522.6) | (364.2) | (195.8) | (59.9) | 56.0 | (65.2) | (54.2) | (40.2) |
| Accumulated Other Comprehensive Income | 0.2 | 0.2 | 0.2 | (0.7) | 0 | (863.6) | 0 | (69.1) |
| Total Stockholders' Equity | 275.4 | 438.9 | 555.2 | 640.6 | 710.1 | 547.8 | 19.5 | (36.2) |
| Total Liabilities & Equity | 315.2 | 464.7 | 595.0 | 666.7 | 772.9 | 863.6 | 22.1 | 34.9 |
| Debt Metrics | ||||||||
| Total Debt | 0.8 | 1.6 | 2.4 | 3.1 | 0.2 | 0 | 0 | 0 |
| Net Debt | (94.9) | (63.1) | (141.4) | (643.6) | (764.2) | (850.1) | (21.7) | (34.5) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (158.3) | (168.4) | (136.0) | (115.9) | 121.2 | (10.9) | (14.0) | (9.1) |
| Depreciation & Amortization | 0.4 | 0.4 | 0.4 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 |
| Stock-Based Compensation | 20.7 | 51.8 | 49.4 | 46.7 | 39.6 | 7.5 | 0.6 | 0.4 |
| Change in Working Capital | 16.5 | (7.5) | 16.2 | (46.6) | (247.8) | 300.2 | 0.6 | 0.7 |
| Other Non-Cash Items | (4.9) | (11.8) | 33.1 | (5.5) | 29.4 | 0 | 0.5 | 0.5 |
| Operating Cash Flow | (132.0) | (135.5) | (85.4) | (121.0) | (87.0) | 296.7 | (12.8) | (7.9) |
| Investing Activities | ||||||||
| Capital Expenditure | 0 | 0 | 0 | (1.9) | (0.0) | (0.0) | (0.0) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (281.9) | (461.2) | (562.4) | (545.4) | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 470.7 | 517.3 | 602.7 | 91.9 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (0.5) | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 188.8 | 56.1 | 40.3 | (455.4) | (0.0) | (0.0) | (0.0) | (0.0) |
| Financing Activities | ||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | (25.5) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.5) | 0 | 0 | 0.1 | 0 | 0 | 0 | 27.5 |
| Financing Cash Flow | (25.7) | 0.3 | 0.3 | 0.4 | 1.5 | 531.7 | (0.0) | 27.5 |
| Cash Position | ||||||||
| Net Change in Cash | 31.0 | (79.1) | (44.8) | (576.0) | (85.5) | 828.5 | (12.8) | 19.6 |
| Cash at Beginning | 64.7 | 143.8 | 188.7 | 764.7 | 850.2 | 21.8 | 34.6 | 15.0 |
| Cash at End | 95.7 | 64.7 | 143.8 | 188.7 | 764.7 | 850.2 | 21.8 | 34.6 |
| Free Cash Flow | (132.0) | (135.5) | (85.4) | (122.9) | (87.0) | 296.7 | (12.8) | (7.9) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 351.4 | 48.6 | 0 | 0 |
| Gross Profit | 0 | (83.4) | (70.1) | (62.4) | 184.2 | 10.6 | (0.0) | (0.0) |
| Operating Income | (180.9) | (192.9) | (164.2) | (130.7) | 138.4 | (11.0) | (14.6) | (9.5) |
| Net Income | (158.3) | (168.4) | (136.0) | (115.9) | 121.2 | (10.9) | (13.5) | (9.1) |
| EPS (Diluted) | -1.94 | -2.00 | -1.63 | -1.39 | 1.37 | -0.13 | -0.16 | -0.90 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 95.7 | 64.7 | 143.8 | 646.7 | 764.4 | 850.1 | 21.7 | 34.5 |
| Total Assets | 315.2 | 464.7 | 595.0 | 666.7 | 772.9 | 863.6 | 22.1 | 34.9 |
| Total Debt | 0.8 | 1.6 | 2.4 | 3.1 | 0.2 | 0 | 0 | 0 |
| Stockholders' Equity | 275.4 | 438.9 | 555.2 | 640.6 | 710.1 | 547.8 | 19.5 | (36.2) |
| Cash Flow | ||||||||
| Operating Cash Flow | (132.0) | (135.5) | (85.4) | (121.0) | (87.0) | 296.7 | (12.8) | (7.9) |
| Capital Expenditure | 0 | 0 | 0 | (1.9) | (0.0) | (0.0) | (0.0) | (0.0) |
| Free Cash Flow | (132.0) | (135.5) | (85.4) | (122.9) | (87.0) | 296.7 | (12.8) | (7.9) |